SCHEMBL9924150

SCHEMBL9924150

O=C(Cc1ccc(Cl)cc1)/N=C(\Nc1cc(F)cc(Cl)c1)N[C@H]1CC[C@H](O)CC1

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.45
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
POLB P06746 1/20 0.40
TP53 P04637 2/20 0.39
MDM2 Q00987 2/20 0.39
GRM4 Q14833 1/20 0.39
THRB P10828 1/20 0.39
SLC6A9 P48067 4/20 0.37
MC5R P33032 1/20 0.37
ACKR3 P25106 1/20 0.37
SLC6A5 Q9Y345 2/20 0.36
SIGMAR1 Q99720 2/20 0.36
MEN1 O00255 1/20 0.36
ALDH1A1 P00352 1/20 0.36
KMT2A Q03164 1/20 0.36
ANO1 Q5XXA6 1/20 0.36
EPHX2 P34913 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9924215 0.85 SLC6A9 (0.41) LMNANPC1RAB9ATP53MDM2
SCHEMBL17206620 0.79 GRM4 (0.39) LMNANPC1RAB9ATP53MDM2
SCHEMBL17206624 0.78 CYP2D6 (0.44) LMNANPC1RAB9AGRM4SLC6A9
SCHEMBL9924222 0.78 CYP2D6 (0.44) LMNANPC1RAB9AGRM4SLC6A9
SCHEMBL9924261 0.77 TRPV1 (0.42) POLBGRM4SLC6A9MC5RMEN1
SCHEMBL9924090 0.74 APOB (0.40) POLBTP53MDM2GRM4SLC6A9
SCHEMBL9924083 0.73 NPC1 (0.44) NPC1RAB9ATP53MDM2GRM4
SCHEMBL9924087 0.73 HSD11B1 (0.39) LMNAGRM4SLC6A9MC5RSLC6A5
SCHEMBL9924086 0.72 ALDH1A1 (0.44) LMNAPOLBGRM4SLC6A9SLC6A5
SCHEMBL9924333 0.71 NPC1 (0.44) NPC1RAB9APOLBGRM4MC5R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9169199-B2 Cycloalkyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereof LYCERA CORPORATION (US) 2015-10-27 US disclosed
US-9169199-B2 Cycloalkyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereof LYCERA CORPORATION (US) 2015-10-27 US disclosed
WO-2012078867-A2 CYCLOALKYL GUANIDINE F1F0-ATPASE INHIBITORS AND THERAPEUTIC USES THEREOF LYCERA CORPORATION (US) 2012-06-14 WO disclosed